CC
Corton Capital Portfolio holdings
AUM
$85.9M
1-Year Return
50.75%
This Quarter Return
-4.08%
1 Year Return
+50.75%
3 Year Return
+186.03%
5 Year Return
–
10 Year Return
–
AUM
$198M
AUM Growth
-$14.9M
(-7%)
Cap. Flow
-$5.47M
Cap. Flow
% of AUM
-2.76%
Top 10 Holdings %
Top 10 Hldgs %
27.28%
Holding
567
New
146
Increased
139
Reduced
127
Closed
154
Top Buys
| 1 |
Intel
INTC
|
+$822K |
| 2 |
Mastercard
MA
|
+$744K |
| 3 |
Carnival Corp
CCL
|
+$742K |
| 4 |
Booking.com
BKNG
|
+$737K |
| 5 |
Live Nation Entertainment
LYV
|
+$713K |
Top Sells
| 1 |
Carvana
CVNA
|
+$1.28M |
| 2 |
H&R Block
HRB
|
+$1.07M |
| 3 |
Rivian
RIVN
|
+$827K |
| 4 |
Pultegroup
PHM
|
+$707K |
| 5 |
Charles Schwab
SCHW
|
+$700K |
Sector Composition
| 1 | Technology | 37.53% |
| 2 | Healthcare | 13.08% |
| 3 | Consumer Discretionary | 10.82% |
| 4 | Financials | 8.55% |
| 5 | Energy | 7.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Medallion Financial
MFIN
$250M
| $183K | 0.09% |
26,100
+2,543
| +11% | +$17.9K |
|
327
Organon & Co
OGN
$2.72B
| $182K | 0.09% |
+10,480
| New | +$182K |
|
328
EyePoint Pharmaceuticals
EYPT
$941M
| $181K | 0.09% |
+22,682
| New | +$181K |
|
329
Dyne Therapeutics
DYN
$1.89B
| $179K | 0.09% |
19,926
+6,793
| +52% | +$60.9K |
|
330
Couchbase
BASE
$1.35B
| $178K | 0.09% |
+10,348
| New | +$178K |
|
331
Navient
NAVI
$1.35B
| $176K | 0.09% |
10,211
-9,367
| -48% | -$161K |
|
332
Stagwell
STGW
$1.43B
| $173K | 0.09% |
36,965
+2,787
| +8% | +$13.1K |
|
333
Enviri
NVRI
$938M
| $171K | 0.09% |
23,718
+1,055
| +5% | +$7.62K |
|
|
RC
334
Ready Capital
RC
$720M
| $171K | 0.09% |
16,921
+4,564
| +37% | +$46.1K |
|
335
Udemy
UDMY
$1.02B
| $171K | 0.09% |
+18,002
| New | +$171K |
|
336
Kura Oncology
KURA
$707M
| $168K | 0.08% |
18,409
+1,018
| +6% | +$9.28K |
|
337
Entrada Therapeutics
TRDA
$201M
| $166K | 0.08% |
10,485
-7,582
| -42% | -$120K |
|
338
Natural Gas Services Group
NGS
$326M
| $161K | 0.08% |
+11,070
| New | +$161K |
|
339
Avidity Biosciences
RNA
$6.18B
| $160K | 0.08% |
25,050
+12,694
| +103% | +$81K |
|
340
Definitive Healthcare
DH
$432M
| $160K | 0.08% |
19,964
+2,898
| +17% | +$23.2K |
|
341
Driven Brands
DRVN
$3.11B
| $159K | 0.08% |
+12,606
| New | +$159K |
|
342
Clarivate
CLVT
$3.01B
| $158K | 0.08% |
23,528
-7,259
| -24% | -$48.7K |
|
343
Pennant Group
PNTG
$847M
| $156K | 0.08% |
14,032
+2,497
| +22% | +$27.8K |
|
344
Ironwood Pharmaceuticals
IRWD
$184M
| $156K | 0.08% |
+16,178
| New | +$156K |
|
345
Archrock
AROC
$4.26B
| $155K | 0.08% |
+12,264
| New | +$155K |
|
346
American Axle
AXL
$723M
| $154K | 0.08% |
+21,151
| New | +$154K |
|
347
Anywhere Real Estate
HOUS
$729M
| $153K | 0.08% |
+23,857
| New | +$153K |
|
348
Biomea Fusion
BMEA
$108M
| $152K | 0.08% |
+11,064
| New | +$152K |
|
349
Enhabit
EHAB
$390M
| $152K | 0.08% |
13,501
+696
| +5% | +$7.83K |
|
350
Tyra Biosciences
TYRA
$646M
| $152K | 0.08% |
+11,009
| New | +$152K |
|